Henipaviruses

References

Key articles

World Health Organization. Nipah virus (NiV) infection. 2017 [internet publication].Full text

World Health Organization. Hendra virus (HeV) infection. 2017 [internet publication].Full text

Australian Government Department of Health. Hendra virus CDNA national guidelines for public health units. November 2016 [internet publication].Full text

Reference articles

1. World Health Organization. Nipah virus (NiV) infection. 2017 [internet publication].Full text

2. World Health Organization. Hendra virus (HeV) infection. 2017 [internet publication].Full text

3. Chua KB, Bellini WJ, Rota PA, et al. Nipah virus: a recently emergent deadly paramyxovirus. Science. 2000 May 26;288(5470):1432-5. Abstract

4. World Health Organization. R&D blueprint. List of blueprint priority diseases. 2018 [internet publication].Full text

5. Rahman M, Chakraborty A. Nipah virus outbreaks in Bangladesh: a deadly infectious disease. WHO South-East Asia Journal of Public Health. 2012 Apr-Jun;1(2):208-12.Full text  Abstract

6. Nahar N, Paul RC, Sultana R, et al. Raw sap consumption habits and its association with knowledge of Nipah virus in two endemic districts in Bangladesh. PLoS One. 2015 Nov 9;10(11):e0142292.Full text  Abstract

7. Centers for Disease Control and Prevention. Update: outbreak of Nipah virus - Malaysia and Singapore, 1999. MMWR Morb Mortal Wkly Rep. 1999 Apr 30;48(16):335-7.Full text  Abstract

8. Chadha MS, Comer JA, Lowe L, et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis. 2006 Feb;12(2):235-40.Full text  Abstract

9. Ching PK, de los Reyes VC, Sucaldito MN, et al. Outbreak of henipavirus infection, Philippines, 2014. Emerg Infect Dis. 2015;21:328-31.Full text  Abstract

10. Arunkumar G, Chandni R, Mourya DT, et al. Outbreak investigation of Nipah virus disease in Kerala, India, 2018. J Infect Dis. 2019 May 24;219(12):1867-78.Full text  Abstract

11. World Health Organization. Disease outbreak news. Nipah virus - India. May 2018 [internet publication].Full text

12. World Health Organization. Disease outbreak news. Nipah virus disease - India. September 2021 [internet publication].Full text

13. Australian Government Department of Health. Hendra virus CDNA national guidelines for public health units. November 2016 [internet publication].Full text

14. Chong HT, Abdullah S, Tan CT. Nipah virus and bats. Neurol Asia. 2009;14:73-76.Full text

15. Pernet O, Schneider BS, Beaty SM, et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun. 2014;5:5342.Full text  Abstract

16. Ong KC, Wong KT. Henipavirus encephalitis: recent developments and advances. Brain Pathol. 2015 Sep;25(5):605-13.Full text  Abstract

17. Field HE, Mackenzie JS, Daszak P. Henipaviruses: emerging paramyxoviruses associated with fruit bats. Curr Top Microbiol Immunol. 2007;315:133-59. Abstract

18. Montgomery JM, Hossain MJ, Gurley E, et al. Risk factors for Nipah virus encephalitis in Bangladesh. Emerg Infect Dis. 2008 Oct;14(10):1526-32.Full text  Abstract

19. Luby SP, Rahman M, Hossain MJ, et al. Foodborne transmission of Nipah virus, Bangladesh. Emerg Infect Dis. 2006 Dec;12(12):1888-94.Full text  Abstract

20. Luby SP, Gurley ES, Hossain MJ. Transmission of human infection with Nipah virus. Clin Infect Dis. 2009 Dec 1;49(11):1743-8.Full text  Abstract

21. Goh KJ, Tan CT, Chew NK, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000 Apr 27;342(17):1229-35.Full text  Abstract

22. Chong HT, Kunjapan SR, Thayaparan T, et al. Nipah encephalitis outbreak in Malaysia, clinical features in patients from Seremban. Neurol J Southeast Asia. 2000;5:61-7.Full text  Abstract

23. Gurley ES, Montgomery JM, Hossain MJ, et al. Person-to-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis. 2007 Jul;13(7):1031-7.Full text  Abstract

24. Field H. Hendra virus infection risks. Neurol Asia. 2009;14:77-8.Full text

25. Chew MH, Arguin PM, Shay DK, et al. Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis. 2000;181:1760-3.Full text  Abstract

26. Wong KT, Tan CT. Clinical and pathological manifestations of human henipavirus infection. Curr Top Microbiol Immunol. 2012;359:95-104.Full text  Abstract

27. Sazzad HM, Luby SP, Ströher U, et al. Exposure-based screening for Nipah virus encephalitis, Bangladesh. Emerg Infect Dis. 2015 Feb;21(2):349-51.Full text  Abstract

28. Playford EG, McCall B, Smith G, et al. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect Dis. 2010 Feb;16(2):219-23.Full text  Abstract

29. Federal Select Agent Program. Select agents and toxins list. 2018 [internet publication].Full text

30. Centers for Disease Control and Prevention. CDC fact sheet: Nipah virus (NiV). 2014 [internet publication].Full text

31. Khan SU, Gurley ES, Hossain MJ, et al. A randomized controlled trial of interventions to impede date palm sap contamination by bats to prevent Nipah virus transmission in Bangladesh. PLoS One. 2012;7(8):e42689.Full text  Abstract

32. Centers for Disease Control and Prevention. CDC fact sheet: Hendra virus disease (HeV). 2014 [internet publication].Full text

33. Broder CC, Xu K, Nikolov DB, et al. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Res. 2013 Oct;100(1):8-13.Full text  Abstract

34. Bossart KN, Rockx B, Feldmann F, et al. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med. 2012 Aug 8;4(146):146ra107.Full text  Abstract

35. Abdullah A, Tin Tan C. Henipavirus encephalitis. In: Tselis AC, Booss J, eds. Handbook of clinical neurology, volume 123: neurovirology. New York, NY: Elsevier; 2014.

36. Hossain MJ, Gurley ES, Montgomery JM, et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis. 2008 Apr 1;46(7):977-84.Full text  Abstract

37. Chandni R, Renjith TP, Fazal A, et al. Clinical manifestations of Nipah virus-infected patients who presented to the emergency department during an outbreak in Kerala State in India, May 2018. Clin Infect Dis. 2020 Jun 24;71(1):152-7. Abstract

38. Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect. 2001 Apr;3(4):289-95. Abstract

39. Tamin A, Harcourt BH, Lo MK, et al. Development of a neutralization assay for Nipah virus using pseudotype particles. J Virol Methods. 2009 Sep;160(1-2):1-6.Full text  Abstract

40. Kaku Y, Noguchi A, Marsh GA, et al. Second generation of pseudotype-based serum neutralization assay for Nipah virus antibodies: sensitive and high-throughput analysis utilizing secreted alkaline phosphatase. J Virol Methods. 2012 Jan;179(1):226-32. Abstract

41. Ramasundrum V, Tan CT, Chua KB, et al. Kinetics of IgM and IgG seroconversions in Nipah infection. Neurol J Southeast Asia. 2000;5:23-8.Full text

42. Siva SR, Chong HT, Tan CT. Ten year clinical and serological outcomes of Nipah virus infection. Neurol Asia. 2009;14:53-8.Full text

43. Chew NK, Goh KJ, Tan CT, et al. Electroencephalography in acute Nipah encephalitis. Neurol J Southeast Asia. 1999;4:45-51.Full text

44. Sarji SA, Abdullah BJ, Goh KJ, et al. MR imaging features of Nipah encephalitis. AJR Am J Roentgenol. 2000 Aug;175(2):437-42.Full text  Abstract

45. Quddus R, Alam S, Majumdar MA, et al. A report of 4 patients with Nipah encephalitis from Rajbari district, Bangladesh in the January 2004 outbreak. Neurol J Southeast Asia. 2004;9:33-7.Full text

46. Selvey LA, Wells RM, McCormack JG, et al. Infection of humans and horses by a newly described morbillivirus. Med J Aust. 1995 Jun 19;162(12):642-5. Abstract

47. O'Sullivan JD, Allworth AM, Paterson DL, et al. Fatal encephalitis due to novel paramyxovirus transmitted from horses. Lancet. 1997 Jan 11;349(9045):93-5. Abstract

48. Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008 Aug 1;47(3):303-27. Abstract

49. Chong HT, Kamarulzaman A, Tan CT, et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol. 2001 Jun;49(6):810-3. Abstract

50. Playford EG, Munro T, Mahler SM, et al. Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study. Lancet Infect Dis. 2020 Apr;20(4):445-54. Abstract

51. Vet Practice Magazine. Hendra antibody for humans trialed in QLD. June 2016 [internet publication].Full text

52. Dawes BE, Kalveram B, Ikegami T, et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model. Sci Rep. 2018 May 15;8(1):7604.Full text  Abstract

53. Sejvar JJ, Hossain J, Saha SK, et al. Long-term neurological and functional outcome in Nipah virus infection. Ann Neurol. 2007;62:235-42.Full text  Abstract

54. Tan CT, Goh KJ, Wong KT, et al. Relapsed and late-onset Nipah encephalitis. Ann Neurol. 2002 Jun;51(6):703-8. Abstract

55. Abdullah S, Chang LY, Rahmat K, et al. Late-onset Nipah virus encephalitis 11 years after the initial outbreak: a case report. Neurol Asia. 2012;17:71-4.Full text

Use of this content is subject to our disclaimer